---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-016085"
form_type: "8-K"
ticker: "LFST"
cik: "0001845257"
company_name: "LifeStance Health Group, Inc."
filed_at: "2022-08-09T23:59:59+00:00"
generated_at: "2026-06-24T02:20:51.320598+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# LifeStance Q2 revenue $209.5M (+31%); net loss $68.7M; lowers FY revenue guidance to bottom of $865-885M range

## Summary
- Revenue $209.5M, +31% YoY; net loss $68.7M (incl $57.5M stock comp).
- Adjusted EBITDA $14.6M flat YoY; Center Margin $59.8M (28.5% of rev).
- Clinicians 5,226 (+31%); net add 237 in Q2; 4 acquisitions closed.
- FY2022 rev guidance lowered to bottom of $865-885M; Adj. EBITDA reaffirmed $63-67M; Q3 rev $216-221M.
- Danish Qureshi appointed COO effective July 1; OBIE online booking live in 9 states.

## SEC filing metadata
- accession: 0000950170-22-016085
- form_type: 8-K
- ticker: LFST
- cik: 0001845257
- company_name: LifeStance Health Group, Inc.
- filed_at: 2022-08-09T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1845257/000095017022016085/0000950170-22-016085-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1845257/000095017022016085/lfst-20220809.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-016085
- JSON: https://secwatch.observer/filing/0000950170-22-016085.json
- Plain text: https://secwatch.observer/filing/0000950170-22-016085.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.